Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Sep;64(3):534–536. doi: 10.1038/bjc.1991.345

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line.

G Citro 1, C Cucco 1, A Verdina 1, G Zupi 1
PMCID: PMC1977636  PMID: 1911196

Full text

PDF
534

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradley G., Juranka P. F., Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta. 1988 Aug 3;948(1):87–128. doi: 10.1016/0304-419x(88)90006-6. [DOI] [PubMed] [Google Scholar]
  2. Citro G., Verdina A., Galati R., Floridi A. Quantitation of adriamycin content by a sensitive immunochemical assay. Anticancer Res. 1988 Jul-Aug;8(4):549–552. [PubMed] [Google Scholar]
  3. Curt G. A., Clendeninn N. J., Chabner B. A. Drug resistance in cancer. Cancer Treat Rep. 1984 Jan;68(1):87–99. [PubMed] [Google Scholar]
  4. Evans W. K., Shepherd F. A., Mullis B. Phase II evaluation of Lonidamine in patients with advanced malignancy. Oncology. 1984;41 (Suppl 1):69–77. doi: 10.1159/000225890. [DOI] [PubMed] [Google Scholar]
  5. Fairchild C. R., Ivy S. P., Kao-Shan C. S., Whang-Peng J., Rosen N., Israel M. A., Melera P. W., Cowan K. H., Goldsmith M. E. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res. 1987 Oct 1;47(19):5141–5148. [PubMed] [Google Scholar]
  6. Floridi A., Lehninger A. L. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys. 1983 Oct 1;226(1):73–83. doi: 10.1016/0003-9861(83)90272-2. [DOI] [PubMed] [Google Scholar]
  7. Floridi A., Paggi M. G., Fanciulli M. Modulation of glycolysis in neuroepithelial tumors. J Neurosurg Sci. 1989 Jan-Mar;33(1):55–64. [PubMed] [Google Scholar]
  8. Juliano R. L., Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976 Nov 11;455(1):152–162. doi: 10.1016/0005-2736(76)90160-7. [DOI] [PubMed] [Google Scholar]
  9. Kaplan O., Navon G., Lyon R. C., Faustino P. J., Straka E. J., Cohen J. S. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. Cancer Res. 1990 Feb 1;50(3):544–551. [PubMed] [Google Scholar]
  10. Kim J. H., Alfieri A., Kim S. H., Young C. W., Silvestrini B. Radiosensitization of Meth-A fibrosarcoma in mice by Lonidamine. Oncology. 1984;41 (Suppl 1):36–38. doi: 10.1159/000225883. [DOI] [PubMed] [Google Scholar]
  11. Lyon R. C., Cohen J. S., Faustino P. J., Megnin F., Myers C. E. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res. 1988 Feb 15;48(4):870–877. [PubMed] [Google Scholar]
  12. Malorni W., Arancia G., De Martino C., Nista A., Accinni L., Masella R., Cantafora A. On the mechanism of action of lonidamine: a study on human erythrocyte membrane. Exp Mol Pathol. 1988 Dec;49(3):361–372. doi: 10.1016/0014-4800(88)90008-1. [DOI] [PubMed] [Google Scholar]
  13. Ozols R. F., Deisseroth A. B., Javadpour N., Barlock A., Messerschmidt G. L., Young R. C. Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen. Cancer. 1983 May 15;51(10):1803–1807. doi: 10.1002/1097-0142(19830515)51:10<1803::aid-cncr2820511008>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  14. Pronzato P., Amoroso D., Bertelli G., Conte P. F., Cusimano M. P., Ciottoli G. B., Gulisano M., Lionetto R., Rosso R. Phase II study of lonidamine in metastatic breast cancer. Br J Cancer. 1989 Feb;59(2):251–253. doi: 10.1038/bjc.1989.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Raaphorst G. P., Feeley M. M., Heller D. P., Danjoux C. E., Martin L., Maroun J. A., De Sanctis A. J. Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells. Anticancer Res. 1990 Jul-Aug;10(4):923–927. [PubMed] [Google Scholar]
  16. Zupi G., Greco C., Laudonio N., Benassi M., Silvestrini B., Caputo A. In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin. Anticancer Res. 1986 Sep-Oct;6(5):1245–1249. [PubMed] [Google Scholar]
  17. van der Bliek A. M., Borst P. Multidrug resistance. Adv Cancer Res. 1989;52:165–203. doi: 10.1016/s0065-230x(08)60213-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES